重大公告

Announcements

OBI filed application for Phase II human clinical trial of first-in-class novel prodrug, OBI-3424, to TFDA

1.Date of occurrence of the event:2023/02/02 2.New drug name or code: first-in-class novel prodrug, OBI-3424 3.Indication: OBI-3424 is converted into a potently cytotoxic DNA alkylating …

Announcements

Announcement on behalf of AP Biosciences that application for Phase I human clinical trial of Bispecific Antibody, AP505, has been granted by US FDA

1.Date of occurrence of the event: 2023/01/14 2.New drug name or code: Bispecific Antibody, AP505 3.Indication: Bispecific antibody AP505 is a novel cancer immunotherapy developed …

Announcements

Announcement of BOD’s resolution to lift the non-competition restrictions for new CEO

1.Date of the board of directors resolution: 2022/12/30 2.Name and title of the managerial officer with permission to engage in competitive conduct: Yun Yen / …

Announcements

Announcement of change of CEO

1.Date of the board of directors resolution or date of occurrence of the change: 2022/12/30 2.Position (Please enter chairperson or president/general manager): CEO 3.Name of …

Announcements

Announcement of change of the spokesperson

1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information …